Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cardiogenesis (cgcp) -- Ignore unavailable to you. Want to Upgrade?

To: DCOS who wrote (17)	10/22/1997 11:50:00 AM
From: John Martin	Read Replies (2) \| Respond to of 66

I haven't been closely following CGCP. I watch them as a group. My focal point has been PLC because they are the leader in the industry and will be the first to the US market. As far as qtr estimate - no clue. Developing this technology plus getting through the FDA process is extremely costly. The fact that Medicaid stopped covering the cost of this procedure for patients has hurt all of the companies and their losses are going to stack up. Check out my post about PLC exchange2000.com John